Skyscape Web Viewer : FITZPATRICK'S COLOR ATLAS AND SYNOPSIS OF CLINICAL DERMATOLOGY : Main Index

View All
Drug-Induced Alopecia
Drug-induced pemphigus vegetans
Drug-induced phototoxic photosensitivity
Drug-induced pigmentation clinical manifestations - Figure 217 Drug-Induced Pigmentation clinical manifestations clinical manifestations - Figure 218 overview
Drug-induced urticaria
See also specific drugs and types adverse cutaneous melanin hyperpigmentation from melanin hyperpigmentation from - Figure 1 adverse cutaneous, with HIV - Table melanin hyperpigmentation from - Figure nail changes - Figure
Drugs, for dermatologic disorders in pregnancy categories - Table safe treatments - Table
Drug Use in Pregnancy
Dyshidrotic eczematous dermatitis Dyshidrotic Eczematous Dermatitis - Figure 20 Dyshidrotic Eczematous Dermatitis
Dysplastic melanocytic nevus clinical manifestations - Figure 220 clinical manifestations - Table diagnosis and differential diagnosis - Table 3 epidemiology management pathogenesis clinical manifestations - Figure 219 clinical manifestations - Figure 221 diagnosis and differential diagnosis Dysplastic Melanocytic Nevus (DN) laboratory examinations overview
See also Dysplastic melanocytic nevus Dysplastic Nevus Melanoma Dysplastic Melanocytic Nevus (DN) Melanocytic Nevus See Dysplastic melanocytic nevus
Drug rash with eosinophilia and systemic symptoms (DRESS)
Dystrophic epidermolysis bullosa (DEB) Generalized Atrophic Benign Epidermolysis Bullosa (Gabeb) Hereditary Epidermolysis Bullosa (EB) Classification of Epidermolysis Bullos Generalized Recessive Dystrophic Epidermolysis Bullosa (RDEB Schematic of the Components of Dermal-Epidermal Basement Membrane and Levels of Dermal-Epidermal Separation in Hereditary and Autoimmune Bullous Diseases with Dermal-Epidermal Cleavage Discussed in This Atlas